CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-29 | O'NEIL PATRICK R. EVP CLO & General Counsel | Other acquisition | +331 | $27.71 | $9K | 57,130 |
| 2025-08-29 | Monia Brett P Chief Executive Officer | Other acquisition | +189 | $27.71 | $5K | 180,009 |
| 2025-08-29 | Geary Richard S EVP, Chief Development Officer | Other acquisition | +165 | $27.71 | $5K | 89,657 |
| 2025-08-29 | BENNETT C FRANK EVP, Chief Scientific Officer | Other acquisition | +213 | $27.71 | $6K | 93,679 |
| 2025-08-29 | Birchler Brian EVP, Corp and Development Ops | Other acquisition | +166 | $27.71 | $5K | 56,826 |
| 2025-08-22 | Diaz Allene M. Director | Sale 10b5-1 | −1,427 | $42.53 | $61K | 18,368 |
| 2025-08-18 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise 10b5-1 | +10,000 | $32.60 | $326K | 103,466 |
| 2025-08-18 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale 10b5-1 | −10,000 | $43.98 | $440K | 93,466 |
| 2025-08-18 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −10,000 | 18,869 | ||
| 2025-08-06 | PARSHALL B LYNNE Director | Sale 10b5-1 | −4,600 | $41.87 | $193K | 86,744 |
| 2025-08-06 | PARSHALL B LYNNE Director | Sale 10b5-1 | −400 | $42.63 | $17K | 86,344 |
| 2025-08-05 | Geary Richard S EVP, Chief Development Officer | Sale 10b5-1 | −10,000 | $42.86 | $429K | 89,492 |
| 2025-08-04 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Sale 10b5-1 | −9,549 | $42.80 | $409K | 51,507 |
| 2025-07-30 | Monia Brett P Chief Executive Officer | Option exercise 10b5-1 | +2,432 | $32.60 | $79K | 182,252 |
| 2025-07-30 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −2,432 | $45.00 | $109K | 179,820 |
| 2025-07-30 | Monia Brett P Chief Executive Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −2,432 | 99,057 | ||
| 2025-07-15 | LOSCALZO JOSEPH Director | Option exercise | +4,079 | 36,330 | ||
| 2025-07-15 | LOSCALZO JOSEPH Director | Option exercise · Restricted Stock Unit | −4,079 | 5,220 | ||
| 2025-07-15 | YANG MICHAEL J. Director | Option exercise | +4,079 | 6,010 | ||
| 2025-07-15 | YANG MICHAEL J. Director | Option exercise · Restricted Stock Unit | −4,079 | 9,080 |
Page 28 of 34 · 668 trades